The Principal Scientific Adviser (PSA) to the Government of India Prof. K. VijayRaghavan addressed members from
for development of newer drugs for drug-resistant infectious diseases
for the prestigious occasion meet on "Antimicrobial Resistance: Need for a United Front". CSIR-IMTech is pleased
IMTECH has successfully signed a Research Agreement with Kumar Organics Pvt Ltd (KOPL) based out of Bengaluru,
CSIR-IMTech has entered into a new collaboration with global pharmaceutical company, Johnson and Johnson
The BCG vaccine provides immunity to TB only during childhood, this protection lapses as time goes by and the
TECHNOLOGY DEVELOPMENT: The primary mandate of the Institute is to use the tools of modern biology/ microbial
Natural Streptokinase, Recombinant Streptokinase, Clot-Specific Streptokinase, Anti thrombotic clot
CSIR-Institute of Microbial Technology (CSIR-IMTECH) and Indian Pharmacopoeia Commission signed a Memorandum
List of Novel genera: Albirhodobacter marinus gen. nov 11277 Aquimonas voraii gen. nov., sp. nov.
I. Understanding regulatory mechanisms pertaining to microbial pathogenesis Part A: Understanding the
Rec and PEGylated Staphylokinase (IPR secured) New Immuno-inhibitors and bioactives (leads) Biosensors
The course is intended mainly for graduate students and postdoctoral researchers in the area of structural
Virology Discovery Unit (VDU), CSIR-IMTECH is organising a National Workshop on “Recent Trends in Viral
Screen Reader Access
